Please enter a valid month/year e.g. 01/2015

Pick a date between March 2000 and July 2016

Showing 1 to 10 of 298
Title Reference number Published Last updated
Lumacaftor–ivacaftor for treating cystic fibrosis homozygous for the F508del mutation Reference number:TA398 TA00398 Published:July 2016 20160701 Last updated:July 2016 20160727
Azacitidine for treating acute myeloid leukaemia with more than 30% bone marrow blasts Reference number:TA399 TA00399 Published:July 2016 20160701 Last updated:July 2016 20160727
Nivolumab in combination with ipilimumab for treating advanced melanoma Reference number:TA400 TA00400 Published:July 2016 20160701 Last updated:July 2016 20160727
Abiraterone for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated Reference number:TA387 TA00387 Published:April 2016 20160401 Last updated:July 2016 20160727
Abiraterone for castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimen Reference number:TA259 TA00259 Published:June 2012 20120601 Last updated:July 2016 20160727
Adalimumab for treating moderate to severe hidradenitis suppurativa Reference number:TA392 TA00392 Published:June 2016 20160601 Last updated:June 2016 20160622
Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia Reference number:TA393 TA00393 Published:June 2016 20160601 Last updated:June 2016 20160622
Evolocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia Reference number:TA394 TA00394 Published:June 2016 20160601 Last updated:June 2016 20160622
Ceritinib for previously treated anaplastic lymphoma kinase positive non-small-cell lung cancer Reference number:TA395 TA00395 Published:June 2016 20160601 Last updated:June 2016 20160622
Trametinib in combination with dabrafenib for treating unresectable or metastatic melanoma Reference number:TA396 TA00396 Published:June 2016 20160601 Last updated:June 2016 20160622